The Bay Area World Malaria Day Forum hosted by the Center for Malaria and Vector-Borne Diseases (CMVBD) at the UCSF Institute for Global Health Sciences will take place on Friday, April 24, from 9 AM to noon PT at UCSF’s Mission Bay Campus. World Malaria Day (WMD) is a global event that raises awareness about malaria and builds momentum to defeat this deadly disease. The 2026 WMD theme, “United Against Malaria,” calls for urgent global action and commitment to end malaria once and for all. For Bay Area malaria researchers, advocates, organizations, and funders, this forum is an opportunity to gather, exchange information and ideas, and build collaboration for the malaria fight.
Search
New Report: Making Country-Led Malaria Control a Reality
Friends of the Global Fight, Chevron Read More.
Making Smarter Vector Control A Reality
Interventions that reduce mosquito populations and prevent bites are an essential part of successful malaria control and elimination strategies, but challenges like growing insecticide resistance and climate change require new tools. As countries introduce next-generation mosquito nets and explore novel approaches like genetically modified mosquitos, what does it really take to deliver effective vector control? Drawing on experiences from leading experts, this PATH Live Forum session will explore the successful approaches and lessons learned from rolling out new vector control innovations in the communities hit hardest by malaria.
Launch of the UCSF Center for Malaria and Vector-Borne Diseases
Join UCSF Institute for Global Health Sciences for the inaugural research symposium and launch of the new Center for Malaria and Vector-Borne Diseases (CMVBD). Both events will be held on September 29, 2025 at the UCSF Mission Bay campus.
Expanding the Impact of Chemoprevention
In this PATH Live Forum, this webinar will explore the future of malaria chemoprevention: how strategies are evolving, what we’re learning from implementation, and what’s needed to deliver these tools more widely and equitably.
The Future of Malaria Vaccines: Innovation, Access, and Impact
This webinar will explore what comes next for malaria vaccine development and access. Experts will discuss the future pipeline of malaria vaccines, the challenges and opportunities in integrating vaccines into immunization programs, and the complexities of forecasting and manufacturing supply to meet demand. Join PATH for a dynamic discussion on how these factors shape equitable access and the global effort to reduce malaria’s burden.
Should AIDS, TB and Malaria Remain a Focus in Global Health?
Friends of the Global Fight Read More
Medic and Audere Partner With Kenyan and Ugandan Governments to Advance AI-Powered Malaria Diagnostics
Audere Read More
AKU, Local and Global Partners Launch Landmark Malaria Elimination Project in Thatta
Zenysis Read More
Powering Progress: Immunization, Malaria, and What’s Next in Global Health
JSI Read More
Malaria Nearly Took My Life. Innovation May Be What Finally Ends It, If We Let It.
GHTC Read More
A Total of USD 12.7 Million Investment in New Diagnostics and Drug Development for NTDs and Malaria to Partners
DNDi, PATH Read More
2024 Was a Milestone Year for Tackling Malaria in the Central African Republic. Here’s Why.
AMP Health Read More
New Baseline Study: Biometrically Verifying Malaria Vaccine Delivery in Ghana
Simprints Read More
UCSF’s Malaria Elimination Initiative Receives New Funding to Advance Elimination Goals
UCSF Read More
Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug
Kainomyx Read More
A proactive approach to fighting malaria within communities
PATH Read More
How the first malaria vaccine cleared the way for a second
PATH Read More
AIDS 2024: Scaling public-private partnerships in prevention and behaviour change
Join the Bureau of Global Health Security and Diplomacy, The Global Fund to Fight AIDS, Tuberculosis and Malaria, United States Agency for International Development, Bill & Melinda Gates Foundation, Johnson and Johnson and Project Last Mile for a satellite session at AIDS 2024 on July 22, 2024 at 11:30 AM CET. This satellite session will focus on highlighting examples of partnerships that are creating impact in prevention and behavior change for improved program delivery across key health priorities including HIV, TB and Malaria. The session will tackle topics such as: how to effectively leverage consumer insights to address HIV and TB, components for launching successful PPPs, challenges of effective prevention and behavior change programs for HIV and TB including barriers and opportunities to scale behavior-focused prevention.
Tailoring malaria interventions to high–risk groups in Senegal
PATH Read More




















